Company: TELO
Filing Date: 2025-05-21
Form Type: 8-K
Source: 0001641172-25-011938
Chunk: 2

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-05-21
Form: 8-K
Item: Item 3.02
Chunk 2
---
2025, between Telomir Pharmaceuticals, Inc. and Alan Weichselbaum.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover                                                                                                   

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                           TELOMIR PHARMACUTICALS, INC.                               
  Dated: May 21, 2025      By:                               /s/                      
                           Name:                             Erez Aminov              
                           Title:                            Chief Executive Officer